EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current and future methods of probiotic therapy for necrotizing enterocolitis

Nitin Sajankila, Samantha Jane Wala, Mecklin Victoria Ragan, Samuel Grant Volpe, Zachary Dumbauld, Nanditha Purayil, Belgacem Mihi, Gail E Besner

Frontiers in Pediatrics · 02.03.2023 · 11

DOI: 10.3389/fped.2023.1120459 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pediatrics, online erschienen am 02.03.2023. Verfasst von Nitin Sajankila und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Center for Perinatal Research, Nationwide Children's Hospital, Columbus, OH, United States. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Necrotizing enterocolitis (NEC) is a complex intestinal disease that primarily affects premature neonates. Given its significant mortality and morbidity, there is an urgent need to develop improved prophylactic measures against the disease. One potential preventative strategy for NEC is the use of probiotics. Although there has been significant interest for decades in probiotics in neonatal care, no clear guidelines exist regarding which probiotic to use or for which patients, and no FDA-approved products exist on the market for NEC. In addition, there is lack of agreement regarding the benefits of probiotics in neonates, as well as some concerns about the safety and efficacy of available products. We discuss currently available probiotics as well as next-generation probiotics and novel delivery strategies which may offer an avenue to capitalize on the benefits of probiotics, while minimizing the risks. Thus, probiotics may still prove to be an effective prevention strategy for NEC, although further product development and research is needed to support use in the preterm population.

Schlagwörter

Stichwörter der Autor:innen

NECdysbiosisgutintestinemicrobiomenecrotizing enterocolitisprobiotic

Autor:innen und Institutionen

  • Department of Pediatric Surgery, Center for Perinatal Research, Nationwide Children's Hospital, Columbus, OH, United States.

Förderung

  • NIGMS NIH HHS
  • NIAID NIH HHS
  • NIDDK NIH HHS
  • NIH
  • Ohio State University
  • The Research Institute at Nationwide Children’s Hospital
  • Department of Surgery, Nationwide Children’s Hospital

Zitieren

APA

Sajankila, N., Wala, S. J., Ragan, M. V., Volpe, S. G., Dumbauld, Z., Purayil, N., Mihi, B., & Besner, G. E. (2023). Current and future methods of probiotic therapy for necrotizing enterocolitis. Frontiers in Pediatrics, 11. https://doi.org/10.3389/fped.2023.1120459

Vancouver

Sajankila N, Wala SJ, Ragan MV, Volpe SG, Dumbauld Z, Purayil N, et al. Current and future methods of probiotic therapy for necrotizing enterocolitis. Frontiers in Pediatrics. 2023;11. doi:10.3389/fped.2023.1120459

BibTeX
@article{Sajankila2023,
  author = {Sajankila, Nitin and Wala, Samantha Jane and Ragan, Mecklin Victoria and Volpe, Samuel Grant and Dumbauld, Zachary and Purayil, Nanditha and Mihi, Belgacem and Besner, Gail E},
  title = {Current and future methods of probiotic therapy for necrotizing enterocolitis},
  journal = {Frontiers in Pediatrics},
  year = {2023},
  volume = {11},
  doi = {10.3389/fped.2023.1120459}
}
Kostenlos starten →